开发和评估伊朗的去中心化框架 基于良好治理指标的药品监管体系
Sajjad Esmaeili1, Mohammad Peikanpour1, Farzad Peiravian1
1Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iranian journal of pharmaceutical research : IJPR
|October 20, 2025
概括
分权化制药监管任务可以增强良好的治理. 关键步骤包括立法改革和加强基础设施,以有效利用产能.
科学领域:
- 公共管理 公共管理
- 卫生政策 卫生政策
- 制药法规 制药法规 制药法规
背景情况:
- 分权化政策对于行政改革和提高政府服务效率至关重要.
- 有效地实施去中心化促进了行政系统内的强有力的治理.
研究的目的:
- 提出一个框架来分散制药行业内的监管任务.
- 通过制药部门的去中心化,加强良好的治理指标.
主要方法:
- 定性阶段:使用面试问题指南 (IQG) 评估去中心化框架的重点小组讨论 (FGD).
- 定量阶段:对制药公司,伊朗食品和药物管理局 (IFDA) 员工和食品和药物事务副总理办公室 (VCFDA) 工作人员对监管任务的看法进行评估.
- 评估的指标:透明度,法治,问责制,有效性,效率和利益相关方参与.
主要成果:
- 专家建议授权科学检查和药物采购政策制定,并将监督任务分散在VCFDA监督下.
- 立法修正案,监管基础设施的加强和流程改革被确定为关键建议.
- 量化数据显示,IFDA和制药公司之间的观点存在显著差异,透明度是公司的高分,IFDA/VCFDA员工的响应/问责.
结论:
- 分权化可以在满足关键要求时改善制药行业的良好治理指标.
- 加强监管基础设施和任务明确性对于有效利用政府和非政府组织的能力至关重要.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
489
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
489
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Global Regulatory Systems
598
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
598
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166
In Vitro Drug Release Testing: Overview, Development and Validation
303
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
303
Biopharmaceutical Factors Influencing Drug Product Design: Overview
232
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
232


